Business Standard

Friday, December 20, 2024 | 09:35 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Hetero to deliver first set of 20,000 vials of Remdesivir as DCGI approves

One set would be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra

remdesivir, coronavirus
Premium

Covifor is a generic brand of Remdesivir which is used for the treatment of Covid-19 in adults and children hospitalised with strong symptoms of the disease

Press Trust of India
Following the approval of Covfir, the generic version of Remdesivir, by the Drug Controller General of India (DCGI), Hetero Healthcare Limited is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each.

One set would be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra, a press release from the city-based drug-maker said.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements, the release said.

Managing director of Hetero Healthcare M

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in